Animal FeedLivestockPet CareHealth DiagnosticsPain ManagementGeneticsPet Food and SuppliesVaccinesAgricultureBiotechnologyHealth CareMedicalPharmaceutical
Description
Zoetis Inc. (Zoetis) operates in the animal health industry, focuses on the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health.…
Analysis
Quality compounder
Zoetis Inc. earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is attractive. The owner-earnings multiple stands at 13.3×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 1% a year, against analyst forecasts of 7%. The price, in other words, assumes less than the experts do.
Growth is tepid; the safety picture is stretched. The company scores 16/20 on our value-creation score: strong value creator.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202366
93
2023202420252026
All-time high
93
Jun 2026
All-time low
28
Jan 2025
Average rank
57
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
69
7
7
10
Price/Earnings
36
34
28
22
Price/Book
15
1
1
1
Dividend Yield
97
84
86
85
Value (overall)
92
45
17
23
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.